BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Clinical Outcome
5 results:

  • 1. Primary mediastinal germ cell tumor and clonally related and unique hematologic neoplasms with i(12p) and tp53 mutation: A report of two cases.
    Fang H; Toruner GA; Tang Z; Tang G; Weissferdt A; Tashakori M; El Hussein S; Thakral B; Quesada AE; Wang W; Patel KP; Garcia-Manero G; Medeiros LJ; Bueso-Ramos CE; Jelloul FZ
    Ann Diagn Pathol; 2022 Aug; 59():151951. PubMed ID: 35489185
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor outcome in Male Malignant Germ Cell Tumors.
    Timmerman DM; Eleveld TF; Sriram S; Dorssers LCJ; Gillis AJM; Schmidtova S; Kalavska K; van de Werken HJG; Oing C; Honecker F; Mego M; Looijenga LHJ
    J Clin Oncol; 2022 Sep; 40(26):3077-3087. PubMed ID: 35442716
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. p53 and MDM2 expression in primary and metastatic testicular germ cell tumors: Association with clinical outcome.
    Lobo J; Alzamora MA; Guimarães R; Cantante M; Lopes P; Braga I; Maurício J; Jerónimo C; Henrique R
    Andrology; 2020 Sep; 8(5):1233-1242. PubMed ID: 32384200
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review.
    Romano FJ; Rossetti S; Conteduca V; Schepisi G; Cavaliere C; Di Franco R; La Mantia E; Castaldo L; Nocerino F; Ametrano G; Cappuccio F; Malzone G; Montanari M; Vanacore D; Quagliariello V; Piscitelli R; Pepe MF; Berretta M; D'Aniello C; Perdonà S; Muto P; Botti G; Ciliberto G; Veneziani BM; De Falco F; Maiolino P; Caraglia M; Montella M; De Giorgi U; Facchini G
    Oncotarget; 2016 Dec; 7(51):85641-85649. PubMed ID: 27821802
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteins.
    Eid H; Géczi L; Mágori A; Bodrogi I; Institoris E; Bak M
    Anticancer Res; 1998; 18(4C):3059-64. PubMed ID: 9713510
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.